Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Diffuse Parenchymal Lung Disease
When do you consider systemic therapy for patients with progressive fibrosing mediastinitis?
Related Questions
How often do you monitor pulmonary function tests in patients with fibrotic lung disease?
What factors do you consider when determining whether to perform a biopsy for the diagnosis of organizing pneumonia?
What is your approach to evaluation and management of GERD in a patient with IPF?
Would you offer lung SBRT in a patient with Pulmonary Langerhans Cell Histiocytosis (PLCH)?
What are your thoughts on using abatacept for RA-associated ILD in a patient undergoing treatment for CLL with zanubrutinib, and how would you assess the potential increased risk of infection in this context?
Have you adopted the use of low dose morphine for treatment of cough in patients with IPF?
How would you approach management of a patient with seropositive RA and UIP-ILD, with concern for active lung disease?
What is your approach to managing ILD associated with inflammatory bowel disease?
What is your approach to counseling and managing patients with LAM desiring pregnancy?
Would you consider adding or switching to pirfenidone for a patient with progressing UIP (based on imaging and PFTs) who is currently on nintedanib?
